The development and validation of a novel LC-MS/MS method for the quantification of cenicriviroc in human plasma and cerebrospinal fluid.

Dilly Penchala, Sujan; Alagaratnam, Jasmini; Challenger, Elizabeth; Amara, Alieu; Else, Laura; Winston, Alan; Khoo, Saye

Dilly Penchala, Sujan; Alagaratnam, Jasmini; Challenger, Elizabeth; Amara, Alieu; Else, Laura; Winston, Alan; Khoo, Saye.

Affiliation

Dilly Penchala S; Department of Pharmacology, University of Liverpool, Liverpool, UK.
Alagaratnam J; Division of Infectious Diseases, Department of Medicine, Imperial College London, London, UK.
Challenger E; Department of Pharmacology, University of Liverpool, Liverpool, UK.
Amara A; Department of Pharmacology, University of Liverpool, Liverpool, UK.
Else L; Department of Pharmacology, University of Liverpool, Liverpool, UK.
Winston A; Division of Infectious Diseases, Department of Medicine, Imperial College London, London, UK.
Khoo S; Department of Pharmacology, University of Liverpool, Liverpool, UK.

Biomed Chromatogr ; 34(1): e4711, 2020 Jan.

Article de En | MEDLINE | ID: mdl-31629375

Sujet(s)
Mots clés

CSF; LC-MS/MS; cenicriviroc; human serum albumin; plasma

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Chromatographie en phase liquide / Spectrométrie de masse en tandem / Imidazoles Limites: Humans Langue: En Journal: Biomed Chromatogr Année: 2020 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google